Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
July 25, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
Close Move
All Press Releases for March 18, 2008 Subscribe to this News Feed      
 

Stopping Insulin Resistance Before It Leads to Diabetes

Johns Hopkins Health Alerts reports on new research which has identified a fat cell protein that may predict insulin resistance and help doctors to prescribe treatments to slow the development of type 2 diabetes.

New York, NY (PRWEB) March 18, 2008 -- Johns Hopkins Diabetes Health Alerts recently reviewed new research on type 2 diabetes, in which a fat cell protein has been identified that may predict insulin resistance. This biomarker could help doctors to prescribe treatments to slow the development of type 2 diabetes.

WHAT IS INSULIN RESISTANCE?
In a healthy person the pancreas makes enough insulin to keep the supply and use of glucose in balance. In diabetes, the glucose balancing system is disrupted, either because too little insulin is produced or because the body's cells do not respond to insulin normally -- a condition called insulin resistance. The result is an unhealthy rise in blood glucose levels.

WHAT ARE THE DANGERS OF UNTREATED DIABETES?
If diabetes is left untreated, the two principal dangers are the immediate results of high blood glucose levels (which include excessive urination, dehydration, intense thirst, and fatigue) and long-term complications that can affect your eyes, nerves, kidneys, and large blood vessels.

IS IT P0SSIBLE TO SCREEN FOR INSULIN RESISTANCE?
A screening test to identify people with insulin resistance could allow doctors to prescribe treatments or lifestyle measures to stop or slow the development of type 2 diabetes. Researchers have taken a step toward such a screening test, according to a new study reported in The New England Journal of Medicine (Volume 354, page 2552).

THE STUDY RESULTS
In the study, the researchers identified increased blood levels of a protein produced and secreted by fat cells in people who become insulin resistant. The protein's name: retinol-binding protein 4 (RBP4).

Scientists already know that people with insulin resistance have increased levels of RBP4. The new study found that levels of RBP4 rose in parallel with the severity of insulin resistance in people who were obese or had prediabetes or type 2 diabetes and in healthy people with a family history of the disease.

HOW TO REDUCE INSULIN RESISTANCE
Researchers are trying to determine whether lowering RBP4 with medication makes cells more sensitive to insulin. However, the study also found that about two thirds of the participants were able to decrease their RBP4 levels and reduce insulin resistance with a tried-and-true lifestyle measure: exercise.

For the latest Johns Hopkins Diabetes Health Alerts, please visit:
Johns Hopkins Diabetes Health Alerts

The 2008 Diabetes White Paper teaches you how to manage your Type 1 and Type 2 diabetes and avoid complications, such as nerve damage, heart disease, and retinopathy. This comprehensive guide reviews the latest tools for monitoring your blood glucose and the newest medications for controlling it. For more information, please visit:
http://www.johnshopkinshealthalerts.com/white_papers/diabetes_wp/digital08_landing.html
[Johns Hopkins Diabetes White Paper __title__ Johns Hopkins Diabetes White Paper Information Page

For a Free Special Report titled The Johns Hopkins Guide to Controlling Your Diabetes, please visit:
Johns Hopkins Diabetes White Paper

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/Q291cC1Mb3ZlLVBpZ2ctQ3Jhcy1Ib3JyLVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Digg | Furl It | Spurl | RawSugar | Simpy | Shadows | Blink It | My Web


Other Releases by this Member
OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareIt

Share The News

Submit this press release easily to any of these major bookmarking and social media sites.

CONTACT INFORMATION
JOAN MULLALLY
Johns Hopkins Health Alerts
917-640-4362
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your login.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright